Skip to content 
Being diagnosed with an absence of the uterus or severe uterine factor infertility presents an overwhelming emotional and biological hurdle for women aspiring to build a family. Conditions such as Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome or surgical uterine removal (hysterectomy) historically rendered biological motherhood impossible.
Today, state-of-the-art Assisted Reproductive Technology (ART) combined with Gestational Surrogacy allows women without a functional uterus to have their own genetic children safely and legally.
Understanding Absolute Uterine Factor Infertility (AUFI)
Absolute Uterine Factor Infertility occurs when an embryo cannot implant or develop due to the structural absence or severe dysfunction of the uterus.
Key Causes of AUFI:
- MRKH Syndrome (Congenital Agenesis): Failure of the Müllerian ducts to develop, resulting in uterine aplasia.
- Emergency/Oncological Hysterectomy: Surgical removal of the uterus following severe postpartum hemorrhage or gynecological malignancies.
- Severe Asherman’s Syndrome: Endometrial obliteration due to extensive intrauterine adhesions.
The Clinical Path: Autologous IVF with Gestational Carrier
Women with MRKH retain normal, functioning ovaries. Because ovarian tissue originates from the intermediate mesoderm (separate from the Müllerian structures), egg quality and ovarian reserve remain uncompromised.
Through In Vitro Fertilization (IVF), reproductive endocrinologists retrieve the patient’s own eggs. These eggs are fertilized in the laboratory using the partner’s (or donor’s) sperm to create embryos. Preimplantation Genetic Testing (PGT-A) is performed to screen for chromosomal euploidy. Finally, a healthy embryo is transferred into a Gestational Carrier (GC).
Legal Security and Parentage Rights in the United States
The United States offers the world’s most established legal framework for gestational surrogacy. In surrogacy-friendly states (such as California, Nevada, Illinois, and Florida), Pre-Birth Orders (PBO) or Post-Birth Orders allow intended parents—including women with MRKH using their own oocytes—to be named directly on the birth certificate from the moment of delivery, without requiring adoption procedures.
According to clinical guidelines from the American Society for Reproductive Medicine (ASRM), gestational surrogacy is the primary recommended medical treatment for women diagnosed with absolute uterine factor infertility.
Frequently Asked Questions (FAQ)
Will my child inherit MRKH syndrome if born through a gestational carrier?
MRKH syndrome occurs predominantly as a sporadic development anomaly. Extensive medical literature confirms that the inheritance risk for female offspring born via surrogacy is negligible.
How successful is IVF with a gestational carrier for MRKH patients?
Success rates are exceptionally high. Because MRKH patients are typically young with healthy ovarian reserves, clinical pregnancy rates per transfer with euploid embryos frequently exceed 65–70%.
Sources:
- National Institutes of Health (NIH) / MedlinePlus: Mayer-Rokitansky-Küster-Hauser syndrome genetic and clinical overview.
- Fertility and Sterility Journal (ASRM): Using gestational carriers for absolute uterine factor infertility: Clinical outcomes and ethical considerations.
- Centers for Disease Control and Prevention (CDC): Assisted Reproductive Technology (ART) National Summary Reports.
